Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery

Partnership combines Intellegens’ proprietary AI technology with Optibrium’s expertise in predictive modelling and compound design. Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. By leveraging Intellegens’ AlchemiteTM technology, the partnership will create a “next generation” predictive modelling platform that is capable of delivering more accurate predictions and enabling better decision-making when it comes to the optimisation of compounds.

Read more.